Acadian Asset Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,655
Closed -$158K 1880
2024
Q3
$158K Buy
+9,655
New +$137K ﹤0.01% 1446
2024
Q2
Sell
-23,996
Closed -$316K 1825
2024
Q1
$316K Sell
23,996
-31,935
-57% -$415K ﹤0.01% 1101
2023
Q4
$837K Sell
55,931
-19,794
-26% -$243K ﹤0.01% 908
2023
Q3
$1.11M Buy
75,725
+15,997
+27% +$308K ﹤0.01% 834
2023
Q2
$1.5M Buy
59,728
+48,651
+439% +$816K 0.01% 779
2023
Q1
$164K Sell
11,077
-3,391
-23% -$62.9K ﹤0.01% 1297
2022
Q4
$201K Buy
14,468
+10,907
+306% +$297K ﹤0.01% 1282
2022
Q3
$112K Sell
3,561
-4,213
-54% -$176K ﹤0.01% 1335
2022
Q2
$270K Buy
+7,774
New +$498K ﹤0.01% 1126
2019
Q2
Sell
-201
Closed -$16K 1926
2019
Q1
$16K Buy
+201
New +$17.7K ﹤0.01% 1833
2018
Q1
Sell
-41
Closed -$97K 1742
2017
Q4
$97K Buy
+41
New +$90.6K ﹤0.01% 1103

Other funds holding IMUX

Acadian Asset Management's IMUX Position: Q4 2024 in Review

Acadian Asset Management sold out of Immunic (IMUX) in Q4 2024, closing a stake of 9,655 shares — an estimated $158K sold.

Acadian Asset Management first reported a position in IMUX in Q4 2017 and held it in 11 quarters. The position peaked at $1.5M in Q2 2023. 65 funds tracked by Wall St. Rank hold IMUX as of Q4 2024.

  • Acadian Asset Management reported no remaining Immunic position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 9,655 Immunic shares in Q4 2024, an estimated $158K.
  • Acadian Asset Management first reported a position in Immunic in Q4 2017 and held it in 11 quarters.
  • Acadian Asset Management's Immunic position peaked at $1.5M in Q2 2023.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.